Arcadia Biosciences Profit Margin

The latest profit margin for RKDA is -234.53% as of June 2026. That compares with -139.33% in the prior-year period — down 68.3% year over year. That is below the Materials sector average of 17.03%. Investors often review this figure alongside Arcadia Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, RKDA's profit margin moved from -139.33% to -234.53% — a 68.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arcadia Biosciences's valuation or profitability profile.

Against Materials companies, RKDA currently prints -234.53% for profit margin, while the sector average sits near 17.03%. That is roughly 1477.4% below the sector mean. Large gaps often invite a closer look at Arcadia Biosciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Arcadia Biosciences converts resources into returns. At -234.53%, RKDA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -139.33% in the prior-year period — down 68.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RKDA's profit margin (-234.53%), review year-over-year change from -139.33%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.